<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>49(3)</volume><submitter>Khine A</submitter><journal>Diabetes care</journal><pagination>e46-e48</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12925973</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Glucocorticoids to Manage Cytokine Release Syndrome During Teplizumab Therapy for New-Onset Type 1 Diabetes</pubmed_title><pmcid>PMC12925973</pmcid><pubmed_authors>Quandt Z</pubmed_authors><pubmed_authors>Khine A</pubmed_authors><pubmed_authors>Gitelman S</pubmed_authors><pubmed_authors>Sanda S</pubmed_authors><pubmed_authors>Torok C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Glucocorticoids to Manage Cytokine Release Syndrome During Teplizumab Therapy for New-Onset Type 1 Diabetes</name><description/><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-07-16T18:34:19.014Z</modification><creation>2026-07-11T03:08:37.996Z</creation></dates><accession>S-EPMC12925973</accession><cross_references/></HashMap>